Skip to Content


In the US, Topiramate (topiramate systemic) is a member of the drug class carbonic anhydrase inhibitor anticonvulsants and is used to treat Bipolar Disorder, Borderline Personality Disorder, Bulimia, Diabetic Peripheral Neuropathy, Epilepsy, Fibromyalgia, Lennox-Gastaut Syndrome, Migraine Prevention, Obesity, Seizure Prevention, Seizures, Smoking Cessation, Tourette's Syndrome, Trigeminal Neuralgia and Vulvodynia.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiepileptic agent

Chemical Name

2,3:4,5-Di-O-Isopropylidene-β-D-fructopyranose sulfamate

Foreign Names

  • Topiramatum (Latin)
  • Topiramat (German)
  • Topiramate (French)
  • Topiramato (Spanish)

Generic Names

  • Topiramate (OS: DCF, USAN, BAN, JAN)
  • McN 4853 (IS: McNeil)
  • RWJ 17021-000 (IS)
  • Topiramate (PH: USP 38)

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.